Fingers crossed it’s not just a quick pump so the underwriters can dump their shares, but the volume is definitely compelling and indicates to me this is genuine buying. Not surprisingly either, with a P3 readout for a drug that both reduces progression of wet AMD and increases VA so close now, a valuation closer to $10bn is far more appropriate than one closer to $1bn
Fingers crossed it’s not just a quick pump so the underwriters...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.0¢ |
Change
0.010(1.28%) |
Mkt cap ! $972.5M | |||
| Open | High | Low | Value | Volume |
| 77.0¢ | 80.0¢ | 76.5¢ | $2.836M | 3.591M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 52251 | 77.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.0¢ | 10073 | 1 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |